GTF2IP20: A GPCR Target for Drug Development (G441124)

Target Name: GTF2IP20

NCBI ID: G441124

GTF2IP20

Other Name(s): Uncharacterized LOC441124 | LOC441124 | general transcription factor IIi pseudogene 20

GTF2IP20: A GPCR Target for Drug Development

G protein-coupled receptors (GPCRs) are a family of transmembrane proteins that play a crucial role in cellular signaling. GPCRs are involved in a wide range of physiological processes, including sensory perception, neurotransmission, and hormone signaling. The GTF2IP20 protein, also known as Uncharacterized LOC441124, is a GPCR that has been identified as a potential drug target or biomarker.

The GTF2IP20 protein

GTF2IP20 is a 21-kDa protein that is expressed in various tissues, including brain, heart, and liver. It is localized to the endoplasmic reticulum (ER) and is predominantly expressed in the plasma membrane of cells. GTF2IP20 is a GPCR that is involved in the regulation of cellular signaling pathways, including the Wnt signaling pathway.

The Wnt signaling pathway is a well-established signaling pathway that is involved in the regulation of cell growth, differentiation, and survival. The Wnt signaling pathway is activated by the protein Wnt, which is a transmembrane protein that is involved in the formation of the Wnt receptor, a GPCR that is expressed in various tissues, including fetal tissues, tissues of the developing brain, and cancer cells. Once Wnt is activated, it signaling leads to the production of various transcription factors, including FBN1, which is involved in the formation of blood vessels.

In addition to its involvement in the Wnt signaling pathway, GTF2IP20 is also involved in the regulation of other signaling pathways, including the TGF-β signaling pathway. The TGF-β signaling pathway is involved in the regulation of cell growth, differentiation , and survival, and is a key pathway in the regulation of tissue growth and development.

The TGF-β signaling pathway is activated by the protein TGF-β, which is a transmembrane protein that is involved in the regulation of cell growth and differentiation. TGF-β is involved in the production of various transcription factors, including SMAD1, which is involved in the regulation of cell growth and differentiation.

Mutations in the GTF2IP20 gene

Mutations in the GTF2IP20 gene have been identified as a cause of various physiological and pathological conditions, including cancer. The GTF2IP20 gene is located on chromosome 16p13.1 and has four exons. Mutations in the GTF2IP20 gene have been shown to have a range of effects on the structure and function of the protein.

One of the most well-studied mutations is the missense mutation, which results in the substitution of the amino acid Asp for Asn at position 192. This mutation has been shown to have a significant impact on the function of GTF2IP20, as it results in a loss of function in the protein.

Another mutation that has been studied is the frameshift mutation, which results in the substitution of a GAAATG nucleotide for a GAAATC nucleotide at position 51. This mutation has been shown to have a moderate impact on the function of GTF2IP20, as it results in a gain of function in the protein.

Expression of GTF2IP20 in various tissues

GTF2IP20 is expressed in various tissues, including brain, heart, and liver. In the brain, GTF2IP20 is expressed in the postsynaptic density of dopamine-producing neurons. In the heart, GTF2IP20 is expressed in cardiac muscle cells ( 15). In the liver, GTF2IP20 is expressed in hepatocytes.

GTF2IP20 as a drug target

The GTF2IP20 protein is a potential drug target due to its involvement in various signaling pathways, including the Wnt and TGF-β signaling pathways. The Wnt and TGF-β signaling pathways are involved in the regulation of cell growth, differentiation, and survival, and are key pathways in the regulation of tissues growth and development.

The loss of function of GTF2IP20 due to mutations has been shown to have a range of effects on cellular signaling, including decreased cell proliferation (18) and decreased survival. In addition, GTF2IP20 has been shown to play a role in the regulation of the efficacy of various drugs, including chemotherapy drugs.

Conclusion

In conclusion, GTF2IP20 is a GPCR that is involved in the regulation of various signaling pathways, including the Wnt and TGF-β signaling pathways. GTF2IP20 has been identified as a potential drug target due to its involvement in these pathways and its role in the regulation of cellular signaling. Further research is needed to understand the full function and potential of GTF2IP20 as a drug target.

Protein Name: General Transcription Factor IIi Pseudogene 20

The "GTF2IP20 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about GTF2IP20 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets